TREA

86643143 - ACCRETAMAB

Follow

Information

  • Trademark
  • 86643143
  • Serial Number
    86643143
  • Registration Number
    4851400
  • Filing Date
    May 27, 2015
    9 years ago
  • Registration Date
    November 10, 2015
    8 years ago
  • Transaction Date
    June 28, 2022
    2 years ago
  • Status Date
    May 20, 2022
    2 years ago
  • Published for Opposition Date
    August 25, 2015
    8 years ago
  • Location Date
    November 10, 2015
    8 years ago
  • Status Code
    710
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    SUAREZ, MARIA VICTORIA
  • Attorney Docket Number
    TM15-550
    Attorney Name
    Kaushal Odedra
    Law Office Assigned Location Code
    L20
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
ACCRETAMAB
Case File Statements
  • GS0051: Host cells for medical or clinical use; cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; transfected cells that manufacture antibodies, fragments of antibodies or derivatives of antibodies for medical or clinical use; pharmaceuticals, namely, central nervous system depressants, preparations for ophthalmic use, anti-histaminics, cardiotonics, arrhythmia treating agents, diuretics, hypotensors, prophylactic for the treatment of asthma, antitussives and expectorants, stomachics and digestives, antacids, hormones, namely, pituitary hormones for the treatment of infertility, thyroid hormones for the treatment of hyperthyroidism, anabolic hormones for the treatment of aplastic anemia and osteoporosis, corticosteroids for treatment of hypopituitarism, congenital adrenal hyperplasia, rheumatoid arthritis, rheumatic fever, crohn's disease, and chronic active hepatitis, estrogen and progesterone used as combined oral contraceptives, urinary antiseptics, analgesics, anti-itching agents, cataplasms for the treatment of bruises, lumbago and stiff shoulder, pharmaceutical preparations used to treat hair disorders, vitamin preparations, food enriching agents for treating vitamin deficiencies, anti-coagulants, enzyme preparations for control of malabsorption and diarrhea, anti-cancer preparations, anti-sarcoma preparations, antibiotics and their preparations for the treatment of infectious diseases, antituberculotic agents, influenza vaccines, diphtheria vaccines, tetanus vaccines, gas gangrene vaccines, Japanese encephalitis vaccines, in vitro tetrodotoxines for medical use, antiprotozoals for the treatment of trichomoniasis and dermatophytosis, anthelmintics for the treatment of threadworm and toxoplasmaosis, naturally occurring drugs for treating peptic ulcers, charred drugs for treating peptic ulcers, moxa for treating peptic ulcers, veterinary drugs for the treatment of distemper in dogs, distomatosis in dogs, coccidian in chickens, and dysentery in pigs, germination controllers and plant rearing agents, namely, herbicides, fungicides, insecticides, bactericides and rodenticides for domestic and agricultural use, antiseptics, drugs for arteriosclerosis, oncostatic drugs for the treatment for cancer, multienzyme digestants for in vivo use, antifungal antibiotics for treating trichomoniasis and dermatophytosis, anti parkinsonism drugs, minor tranquilizers, and anti anxiety agents, medicinal preparations for the treatment of the central nervous system, the respiratory tract and the cardiovascular system, anti-bacterial preparations, monolithic preparations, medicinal preparations for the treatment of peptic ulcers, anti-inflammatory preparations, analgesic preparations, cephalosporin, cocarboxylase preparations, glutathione preparations, preparations for improving the metabolism and the peripheral circulation, plasma substitutes and extracorporeal circulation flow improvement preparations, diuretic and anti-hypertensive preparations, in vitro diagnostic reagents for medical use, in vitro extra corporeal diagnostic reagents for medical use, in vitro x-ray contrast agents for medical use, in vitro diagnostic media, and pharmaceutical preparations for the treatment of insomnia and other sleep related diseases
Case File Event Statements
  • 5/20/2022 - 2 years ago
    19 - CANCELLED SEC. 8 (6-YR) Type: C8..
  • 11/10/2020 - 3 years ago
    18 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 9/4/2019 - 4 years ago
    17 - AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP Type: ASGN
  • 11/10/2015 - 8 years ago
    16 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/25/2015 - 8 years ago
    15 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/25/2015 - 8 years ago
    14 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/5/2015 - 8 years ago
    13 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/21/2015 - 8 years ago
    12 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 7/21/2015 - 8 years ago
    11 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/20/2015 - 8 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/20/2015 - 8 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/13/2015 - 8 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 7/1/2015 - 9 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 6/16/2015 - 9 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 6/16/2015 - 9 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 6/16/2015 - 9 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 6/13/2015 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/3/2015 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 5/30/2015 - 9 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP